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Seven to eight species of viral subgenomic mRNAs are produced in coronavirus-infected cells. These mRNAs are
produced in different quantities, and their molar ratios remain constant during viral replication. We studied RNA elements that
affect coronavirus transcription efficiency by characterizing a series of cloned coronavirus mouse hepatitis virus (MHV)
defective interfering (DI) RNAs containing an inserted intergenic sequence, from which subgenomic DI RNA is transcribed
in MHV-infected cells. Certain combinations of upstream and downstream flanking sequences of the intergenic sequence
suppressed subgenomic DI RNA transcription, yet changing one of the flanking sequences to a different sequence eliminated
transcription suppression. The suppressive effect of certain combinations of flanking sequences, but not all combinations,
could be counteracted by altering the intergenic sequence. Thus, the combination of intergenic sequence and flanking
sequence affected transcription efficiency. We also characterized another set of DI RNAs designed to clarify which
transcription step determines the relative molar ratios of coronavirus mRNAs. Our study indicated that if subgenomic mRNAs
were exclusively synthesized from negative-strand genomic RNA, then the relative molar ratios of coronavirus mRNAs were
most likely determined after synthesis of the genomic-sized template RNA. If negative-strand subgenomic RNAs were
templates for subgenomic mRNAs, then the relative molar ratios of coronavirus mRNAs probably were determined after
synthesis of the genomic-sized template RNA used for subgenomic-sized RNA transcription but prior to the completion of the
synthesis of subgenomic-sized RNAs containing the leader sequence. The relative molar ratios of coronavirus mRNAs,
therefore, seem to have been established prior to a putative replicon-type amplification of subgenomic mRNAs. © 1998
Academic Press
INTRODUCTION
Many eukaryotic RNA viruses express their gene(s) by
producing subgenomic mRNA(s) in infected cells. Coro-
navirus, an enveloped virus containing a large positive-
sense single-strand RNA, belongs to this group. Cells
infected with mouse hepatitis virus (MHV), a prototypic
coronavirus, produce seven to eight species of virus-
specific mRNAs that make up a 39 coterminal nested set
structure (Lai et al., 1981; Leibowitz et al., 1981). These
mRNAs, which are named mRNAs 1 through 7 in de-
creasing order of size (Lai et al., 1981; Leibowitz et al.,
1981), are produced in different quantities, and their
molar ratios remain constant during MHV replication.
The 59-end of the MHV genomic RNA and the sub-
genomic mRNAs start with a leader sequence that is
approximately 72 to 77 nucleotides (nt) long (Lai et al.,
1983, 1984; Spaan et al., 1983); the presence of the leader
sequence in subgenomic mRNAs is a unique character-
istic in coronavirus and arterivirus (de Vries et al., 1990),
which is closely related to coronavirus. Curiously, on the
genome, the leader sequence is not found any place
besides the 59-end, yet the subgenomic mRNAs have the
leader sequences fused with the mRNA body se-
quences. The mRNA body sequences begin from a UC-
UAAAC transcription consensus sequence or a very sim-
ilar sequence of intergenic sequences, which is located
upstream of each MHV gene. Coronavirus transcription
undergoes a discontinuous transcription step, in which
the leader sequence somehow joins to the body of the
subgenomic RNA (Jeong and Makino, 1994; Zhang et al.,
1994). Genomic-sized and subgenomic-sized negative-
strand RNAs, each of which corresponds to one of the
subgenomic mRNA species, are also present in corona-
virus-infected cells (Sethna et al., 1989). These negative-
strand RNAs contain an antileader sequence at the 39-
end and a poly U sequence at the 59-end (Sethna et al.,
1991).
Several models have been proposed to explain coro-
navirus subgenomic RNA synthesis. One model pro-
poses that negative-strand RNA synthesis starts on
genomic RNA and terminates at the intergenic sequence
(Sawicki and Sawicki, 1990). In this model, the leader
sequence joins to the body of subgenomic RNA either by
relocalization of negative-strand subgenomic RNA to the
leader sequence of the genomic RNA (antileader se-
quence joins to negative-strand subgenomic RNA), or
during subgenomic mRNA synthesis on negative-strand
subgenomic RNA template (Sawicki and Sawicki, 1990).
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Another way to envision negative-strand subgenomic
RNA synthesis is provided by the idea that processing of
the full-length negative-strand genomic RNA occurs after
transcription from the genome. Subgenomic mRNA syn-
thesis would follow processing of subgenomic negative
strand RNAs; the leader sequence could join the body
sequence during processing of negative-strand genomic
RNA or during subgenomic mRNA synthesis on negative-
strand subgenomic RNA. These two models propose that
negative-strand subgenomic RNAs are synthesized prior
to the synthesis of subgenomic mRNAs. All other tran-
scription models propose that subgenomic mRNAs are
synthesized prior to the synthesis of negative-strand sub-
genomic RNA. Subgenomic mRNAs may be synthesized
by the processing of the positive-strand genomic RNA
(Baric et al., 1983), or by transcription from negative-
strand genomic RNA by a unique leader-primed tran-
scription mechanism, in which short ‘‘free’’ leader RNAs
are used as primers for subgenomic mRNA synthesis
(Baric et al., 1983), or by polymerase jumping from leader
sequence to intergenic sequence during subgenomic
mRNA synthesis on the negative-strand genomic RNA
template (Spaan et al., 1983). In these models, once
subgenomic mRNAs are synthesized, negative-strand
subgenomic RNAs are copied on subgenomic mRNAs.
Negative-strand subgenomic RNAs may have several
different effects on transcription. These negative-strand
subgenomic RNAs may be templates for subgenomic
mRNA synthesis (Sawicki and Sawicki, 1990; Schaad and
Baric, 1994), or may become replicons which undergo
replication to amplify more subgenomic mRNA and neg-
ative-strand subgenomic RNAs (Sethna et al., 1989). Al-
ternatively, these negative-strand subgenomic RNAs may
not participate in subsequent transcription; they may be
dead-end transcription products (Jeong and Makino,
1992). All of the coronavirus transcription models postu-
late several transcription steps for the production of
mature mRNAs; one of these unidentified transcriptions
steps is that which defines the relative molar ratios of
subgenomic mRNAs.
Due to the large size of coronavirus genomic RNA, a
coronavirus infectious cDNA clone has not yet been
constructed. Instead, for studying transcription we use
coronavirus defective interfering (DI) RNAs that contain
an inserted intergenic sequence from which transcrip-
tion in DI RNA-replicating, coronavirus-infected cells
yields a subgenomic DI RNA with a leader sequence
(Makino et al., 1991). Studies using MHV DI RNAs iden-
tified RNA elements that affect transcription (Jeong et al.,
1996; Joo and Makino, 1992, 1995; Makino and Joo, 1993;
Makino et al., 1991; van der Most et al., 1994; van Marle
et al., 1995). One study showed that a series of DI RNAs,
each of which contains a 0.4-kb-long sequence derived
from various regions of the MHV sequence with an
intergenic sequence in the middle, transcribe different
amounts of subgenomic DI RNA (Jeong et al., 1996),
demonstrating that sequences flanking the intergenic
sequence affect transcription. Other studies showed that
differences in the sequence of the inserted intergenic
sequence also affect transcription (Jeong et al., 1996; Joo
and Makino, 1992; van der Most et al., 1994). A DI RNA
containing a 12-nt-long intergenic sequence (12-nt se-
quence) (UCUAAUCUAAAC) that is flanked by 0.2-kb-
long sequences upstream and downstream of the genes
6–7 junction transcribes only a small amount of sub-
genomic DI RNA, while a DI RNA containing an 18-nt-
long naturally occurring intergenic sequence at genes
6-7 (18-nt sequence) (AAUCUAAUCUAAACUUUA) in the
place of the 12-nt sequence transcribes a significantly
higher amount of subgenomic DI RNA (Jeong et al., 1996),
demonstrating that the 18-nt sequence overcomes the
flanking sequence-mediated transcription suppression.
Among the many unanswered questions about coro-
navirus transcription regulation, we addressed the fol-
lowing three questions: (I) Does replacement of the 12-nt
sequence with the 18-nt sequence in the intergenic se-
quence always overcome flanking sequence-mediated
transcription suppression? (II) Does the presence of one
of the flanking sequences or the presence of certain
combinations of upstream and downstream flanking se-
quences suppress transcription? (III) During which step
of transcription are the relative ratios of MHV mRNAs
mainly determined?
RESULTS
In an attempt to test for their susceptibility to transcrip-
tion suppression by flanking sequences, the 18-nt or the
12-nt sequences were independently placed in the mid-
dle of different 0.4-kb sequences that had been inserted
in a complete MHV DIss EcDNA clone, DE5-w3 (Makino
and Lai, 1989b) between the AflII site and the SacII site
(Fig. 1); this placement of the intergenic sequence re-
sulted in its being flanked by two 0.2-kb sequences. We
called the 0.2-kb-long regions that were located up-
stream and downstream of the intergenic sequence the
0.2-kb upstream flanking sequence and the 0.2-kb down-
stream flanking sequence, respectively.
Effect of 18-nt sequence on flanking sequence-
mediated transcription suppression
The 18-nt sequence overcomes the effect of transcrip-
tion suppression that the 0.2-kb upstream and down-
stream flanking sequences exert over the gene 6–7 in-
tergenic sequence (Jeong et al., 1996). We attempted to
confirm this previous observation through a comparison
of the transcripts (of in vitro synthesized DI RNA trans-
fected into MHV-infected cells) from mutants FDI-6/7 M
and FDI-6/7 wt, which both have 0.2-kb insertions up-
stream and downstream of the gene 6–7 intergenic se-
quence, and respectively carry the 12- and 18-nt se-
quence. Northern blot analysis of total cytoplasmic RNAs
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using probe 1, which corresponds to nucleotides 1488–
1610 from the 59-end DE5-w3, showed that FDI-6/7wt
produced a significantly larger amount of subgenomic DI
RNA than FDI-6/7 M (Fig. 2). These data were consistent
with our previous result (Jeong et al., 1996). As shown in
Fig. 2 and subsequent figures, sometimes Northern blot
analyses did not show a distinct MHV-A59 genomic RNA
band; this was probably due to minor degradation of
RNAs.
To examine whether replacement of the intergenic
sequence from the 12-nt sequence to the 18-nt sequence
always overcomes the flanking sequence-mediated tran-
scription suppression, we examined two additional sets
of DI RNAs; one set was FDI-EagIwt and FDI-EagI, and
the other was FDI-NruIwt and FDI-NruI. FDI-EagIwt and
FDI-NruIwt had an insertion of the 0.4-kb region sur-
rounding the EagI site and NruI site of DE5-w3, respec-
tively, and both contained the 18-nt sequence. (Fig. 1).
FDI-EagI and FDI-NruI contain the 12-nt sequence in
place of the 18-nt sequence (Jeong et al., 1996). Northern
blot analysis showed no significant differences in the
molar ratio of subgenomic DI RNA to genomic DI RNA
among these four DI RNAs (Fig. 2). The replacement of
the 12-nt sequence with the 18-nt sequence did not
always overcome transcription suppression by the flank-
ing sequences.
Characterization of transcription suppression
mediated by flanking sequences
To know whether the presence of one of the flanking
sequences or the presence of certain combinations of
upstream and downstream flanking sequences suppress
transcription, we constructed a series of DI RNAs, all of
which contained the 12-nt sequence and had a different
combination of the 0.2-kb upstream and downstream
flanking sequences (Fig. 3). In these clones, one of the
flanking sequences of FDI-EagI, FDI-NruI, and FDI-6/7 M
was replaced with one of the 0.2-kb sequences that flank
the naturally occurring intergenic sequences at genes
6–7, 2–3, and 1–2. Northern blot analysis using a 32P-
labeled probe 1 showed that all of the newly constructed
FIG. 1. Schematic diagram of the structure of MHV genomic RNA, DE5-w3, and DE5-w3-derived insertion mutants with flanking sequences. The
0.2-kb flanking sequences that were inserted into DE5-w3-derived insertion mutants are shown as 0.2-kb fragments. Each mutant has a 0.4-kb-long
insertion between the AflII site and SacII site of DE5-w3. Molar ratio (sG/G) represents the average molar ratio of subgenomic DI RNA to genomic
DI RNA from at least three independent experiments (see Fig. 2). The location of probe 1 used for Northern blot analysis (see Fig. 2) is also shown.
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DI RNAs efficiently transcribed subgenomic DI RNA (Fig.
4). FDI-1/EagI M, which had a naturally occurring 0.2-kb
upstream flanking sequence at gene 1–2 plus a 0.2-kb
downstream flanking sequence of the EagI site, effi-
ciently transcribed subgenomic DI RNA, while FDI-EagI
produced only a very low level of subgenomic DI RNA.
These data may be interpreted as meaning that the
0.2-kb upstream flanking sequence of FDI-EagI con-
tained a transcription suppressive element(s). However,
FDI-EagI/2 M, which had the 0.2-kb upstream flanking
sequence of FDI-EagI and a 0.2-kb-long downstream
flanking sequence at gene 1–2, efficiently transcribed
subgenomic DI RNA; putative transcription suppressive
element(s) at the 0.2-kb upstream flanking sequence did
not suppress transcription. Comparison of FDI-EagI and
FDI-EagI/2 M may indicate the presence of the transcrip-
tion suppressive element(s) at the 0.2-kb downstream
flanking sequence of the EagI site. Again this putative
transcription suppressive element(s) did not work at all
in FDI-1/EagI. These data indicated that the presence of
either the 0.2-kb upstream or downstream flanking se-
quences of the EagI site did not suppress transcription.
Transcription suppression only occurred when the 0.2-kb
upstream and downstream flanking sequences of FDI-
EagI were combined. Studies of the remaining two sets
of DI RNAs resulted in the same conclusion; transcrip-
tion suppression only occurred when the DI RNAs con-
tained both upstream and downstream 0.2-kb fragments
around the NruI site and when DI RNA had both up-
stream and downstream 0.2-kb fragments at the gene
6–7 junction. In addition, we did not see any relation-
ships between the transcription efficiency and the pres-
ence of a large open reading frame in subgenomic DI
RNA among DI RNAs.
Transcription step that determined the molar ratio of
subgenomic DI RNA to genomic DI RNA
For identification of the transcription step that mainly
determines the relative molar ratios of MHV mRNAs, we
first characterized constructs FDI-2/7 M and FDI-6/7 M
(Fig. 5). They only differed from each other in their 0.2-kb
upstream flanking sequence; FDI-2/7 M and FDI-6/7 M
had 0.2-kb upstream flanking sequences from the up-
stream flanking sequences at genes 2–3 and genes 6–7,
respectively (Fig. 5). In repeated experiments, the
genomic DI RNA from the two DI RNAs (Figs. 4 and 6)
replicated with very similar efficiencies. The difference
between the subgenomic DI RNAs of FDI-6/7 M and
FDI-2/7 M, however, was striking; FDI-6/7 M subgenomic
DI RNA was significantly lower than FDI-2/7 M sub-
genomic DI RNA (Figs. 4 and 6). The structures of the
subgenomic DI RNAs of both DI RNAs were expected to
be the same, because both DI RNAs had the 12-nt se-
quence and had the same 0.2-kb downstream flanking
sequence. Sequence analysis of cloned RT-PCR prod-
ucts of subgenomic DI RNA showed that both sub-
genomic DI RNAs had the helper MHV-derived leader
sequence and the same leader–body fusion site (data
not shown); the difference between the leader se-
quences of FDI-6/7 M and FDI-2/7 M and that of helper
virus allowed for the identification of the origin of leader
sequence in the subgenomic DI RNA. These data dem-
onstrated that the subgenomic DI RNAs of both DI RNAs
indeed had the same structure.
FIG. 2. Northern blot analysis of DE5-w3-derived insertion mutants. Intracellular RNAs were extracted from DI RNA-transfected, MHV-infected cells
(lanes 4, 5, 11–14) or DI RNA-transfected, mock-infected cells (lanes 2, 3, 6–9). Lanes 1 and 10 represent RNA from MHV-infected cells. Total
cytoplasmic RNAs (lanes 1–5) or poly(A)-containing RNAs (lanes 6–14) were analyzed by Northern blot analysis using probe 1 (see Fig. 1). Arrowhead
and arrow point to subgenomic DI RNAs and genomic DI RNAs, respectively. The minute amount of genomic DI RNA-sized signal in lanes 2 and 3
represents the transfected DI RNA transcripts that were not degraded in MHV-uninfected cells.
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These data indicated that the molar ratio of sub-
genomic DI RNA to genomic DI RNA was determined at
a transcription step(s) that occurred prior to or concom-
itant with the synthesis of subgenomic-sized DI RNA (of
either polarity) containing leader sequence. The follow-
ing are the logical bases for the previous statement: (I)
The similar replication efficiencies of FDI-6/7 M and
FDI-2/7 M indicated that similar amounts of helper virus-
derived and host-derived factors were available for DI
RNA synthesis of both constructs. (II) Efficiency of puta-
tive RNA synthesis from subgenomic-sized DI RNA tem-
plate containing leader sequence of those identical sub-
genomic DI RNA probably is the same whether they were
positive-stranded, negative-stranded, or both. If sub-
genomic DI RNAs accumulate by replicon-type amplifi-
cation (Sethna et al., 1989), then these subgenomic DI
RNAs with identical structures probably amplify with the
same efficiency. Any difference in the subgenomic to
genomic DI RNA molar ratios of the two DI RNAs, there-
fore, should occur prior to a possible replicon-type am-
plification.
One of the transcription steps that possibly deter-
mines the ratio of subgenomic DI RNA to genomic DI
RNA is the step that synthesizes biologically functional
genomic-sized template RNA; genomic-sized template
RNA may be either positive-stranded or negative-
stranded. FDI-6/7 M might have produced significantly
less genomic-sized transcription-template RNA than did
FIG. 3. Schematic diagram of the structure of MHV genomic RNA, DE5-w3, and DE5-w3-derived insertion mutants with flanking sequences. The
0.2-kb flanking sequences that were inserted into DE5-w3-derived insertion mutants are shown as 0.2-kb fragments. All mutants contained the 12-nt
sequence in the middle of the inserted sequence. Molar ratio (sG/G) represents the average molar ratio of subgenomic DI RNA to genomic DI RNA
from at least three independent experiments (see Fig. 4). The location of probe 1 used for Northern blot analysis (see Fig. 4) is also shown.
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FDI-2/7 M; the sequence differences at the upstream
flanking sequence of these two DI RNAs may be respon-
sible for the differences in the amounts of biologically
active template. Quantitative comparison of negative-
strand or positive-strand DI genomic RNA of FDI-6/7 M
and FDI-2/3 M may not reveal the difference in the
amount of biologically functional template; both DI RNAs
produced similar amounts of positive-strand DI genomic
RNA (Figs. 4 and 6) and may produce similar amounts of
negative-strand DI genomic RNAs, yet the amount of
biologically functional genomic-sized template RNA that
is used for transcription may differ between the two DI
RNAs.
To examine whether FDI-6/7 M and FDI-2/7 M synthe-
sized different amounts of genomic-sized RNA templates
that function for transcription, we constructed and char-
acterized FDI-2/7 M-dIG and FDI-6/7 M-dIG (Fig. 5). FDI-
2/7 M-dIG and FDI-6/7 M-dIG each had an additional
12-nt sequence located 0.2 kb downstream of the 12-nt
sequences of FDI-2/7 M and FDI-6/7 M, respectively.
From these constructs, we expected synthesis of a large
subgenomic DI RNA from the upstream 12-nt sequence
and a small subgenomic DI RNA from the downstream
12-nt sequence. If FDI-6/7 M-dIG and FDI-2/7 M-dIG
replicated at similar efficiencies, and if the molar ratios of
their genomic DI RNAs to their large subgenomic DI
RNAs were respectively similar to those of their parent
constructs, then regulation of the synthesis of the large
subgenomic DI RNA in FDI-2/7 M-dIG and FDI-6/7 M-dIG
is probably similar to regulation of subgenomic DI RNA
synthesis in their individual parents. Along this line, if
one parental construct produced fewer functioning
genomic-sized RNA templates than the other parent, we
expected that the successor constructs would likewise
be related. In this case, FDI-6/7 M-dIG would produce
less small subgenomic DI RNA than FDI-2/7 M-dIG, be-
cause FDI-6/7 M-dIG would have fewer genomic-sized
template RNAs than the corresponding RNA of FDI-2/7
M-dIG. If the number of templates of FDI-2/7 M-dIG and
FDI-6/7 M-dIG are similar, then similar amounts of small
subgenomic DI RNA should be synthesized in FDI-2/7
M-dIG- and FDI-6/7 M-dIG-replicating cells.
Northern blot analysis using probe 2, which corre-
sponds to nucleotides 1235–1491 from the 59-end of
DE5-w3, demonstrated replication of FDI-2/7 M-dIG and
FDI-6/7 M-dIG (Fig. 6). Although FDI-6/7 M-dIG replicated
slightly better than FDI-2/7M-dIG in Fig. 6, this was not
always the case; in other experiments, FDI-2/7 M-dIG
FIG. 4. Northern blot analysis of insertion mutants. Intracellular RNAs were extracted from DI RNA-transfected, MHV-infected cells (lanes 1–4,
10–13, 19, 20, 22, 23) or DI RNA-transfected, mock-infected cells (lanes 6–9, 15–18, 24–27). Lanes 5, 14, and 21 represent RNA from MHV-infected cells.
Poly(A)-containing RNAs were analyzed by Northern blot analysis using probe 1 (see Fig. 1). Arrowhead and arrow point to subgenomic DI RNAs and
genomic DI RNAs, respectively.
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replicated slightly better than FDI-6/7 M-dIG. The aver-
age replication efficiencies of these two DI RNAs were
very similar. The molar ratio of large subgenomic DI RNA
to genomic DI RNA in FDI-2/7 M-dIG and that in FDI-6/7
M-dIG was comparable to that of subgenomic DI RNA to
genomic DI RNA in FDI-2/7 M and FDI-6/7 M, respec-
tively, indicating that transcription regulation in FDI-2/7
M-dIG and in FDI-6/7 M-dIG was the same or very similar
to that in their respective parental constructs. Interest-
ingly, the molar ratio of the small subgenomic DI RNA to
genomic DI RNA in FDI-2/7 M-dIG and that in FDI-6/7
M-dIG was very similar. These data strongly indicated
that the amount of biologically functional genomic-sized
DI RNA template that is used for subgenomic-sized DI
RNA transcription is similar in FDI-2/7 M-dIG and FDI-6/7
M-dIG.
The data indicated that these differences in the molar
ratios of subgenomic DI RNA to genomic DI RNA most
probably were set after the synthesis of genomic-sized
template DI RNA. If coronavirus subgenomic mRNAs are
synthesized exclusively from negative-strand genomic
RNA, differences in the molar ratios of subgenomic DI
RNA to genomic DI RNA should have been determined
after the synthesis of genomic-sized template DI RNA. If
subgenomic-sized negative-strand RNAs are templates
for subgenomic mRNAs, then the molar ratios of sub-
genomic DI RNA to genomic DI RNA should have been
determined after the synthesis of genomic-sized tem-
plate DI RNA that is used for subgenomic-sized DI RNA
transcription but prior to the completion of the synthesis
of subgenomic-sized DI RNAs containing the leader se-
quence.
DISCUSSION
Coronavirus transcription regulation and intergenic
sequence/flanking sequence combinations
An earlier study demonstrated that certain MHV se-
quences that flank an inserted intergenic sequence sup-
press subgenomic DI RNA transcription (Jeong et al.,
1996). The present study showed that transcription sup-
pression only occurred with certain combinations of up-
stream and downstream flanking sequences. No single
flanking sequence showed dominant transcription sup-
pression. These data suggested that both upstream and
downstream flanking sequences affect transcription ef-
ficiency. An alternative interpretation may be that some
flanking sequences, e.g., flanking sequences at genes
1–2 and 2–3 (see Figs. 3 and 4), have a dominant tran-
scription enhancing element(s) that overcomes the sup-
pressive effect caused by other flanking sequences, e.g.,
0.4-kb sequences at the genes 6–7 junction, the EagI
site, and the NruI site. We also showed that changing the
intergenic sequence from a 12-nt sequence to an 18-nt
sequence did not always overcome flanking sequence-
mediated transcription suppression. Because changing
from a 12-nt sequence to an 18-nt sequence increases
the extent of base pairing between the 39-region of
FIG. 5. Schematic diagram of the structure of insertion mutants. The 0.2-kb flanking sequences that were inserted into insertion mutants are shown
as 0.2-kb fragments. Locations of the 12-nt sequence are also shown. Molar ratio represents the average molar ratio of subgenomic DI RNA to
genomic DI RNA from at least three independent experiments (see Fig. 6). The molar ratios of subgenomic DI RNA to genomic DI RNA in FDI-2/7 M
and in FDI-6/7 M, and that of large subgenomic DI RNA to genomic DI RNA in FDI-2/7 M-dIG and in FDI-6/7 M-dIG, are shown as large sG/G. The
molar ratios of small subgenomic DI RNA to genomic DI RNA in FDI-2/7 M-dIG and in FDI-6/7 M-dIG are shown as small sG/G. The location of probe
2 used for Northern blot analysis (see Fig. 6) is also shown.
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leader sequence and the sequence at the intergenic
sequence, these data were consistent with the previous
finding that the extent of base pairing between the leader
sequence and the intergenic sequence does not directly
correlate with transcription efficiency (Joo and Makino,
1992; van der Most et al., 1994). Our data indicated that
the combination of the intergenic sequence with its up-
stream and downstream flanking sequences affected
transcription efficiency. Probably an RNA structure as-
sembled from these regions is important for the effi-
ciency of transcription.
Other studies indicated that some MHV sequences in
addition to the intergenic sequence and its flanking se-
quences also affect coronavirus transcription. We
showed that the number of UCUAA repeats at the 39-end
of the leader sequence regulates the synthesis of certain
mRNA species (Makino and Lai, 1989a; Shieh et al.,
1989). Lai and his colleagues showed that in MHV-in-
fected cells, expression (Liao and Lai, 1994) or transfec-
tion (Lin et al., 1994, 1996) of a positive-strand MHV DI
RNA fragment that contains an inserted intergenic se-
quence and that lacks one part of the DI RNA cis-acting
replication signals (Kim et al., 1993; Kim and Makino,
1995; Lin and Lai, 1993) results in transcription of sub-
genomic DI RNA. Deletion analyses of these DI RNA
fragments indicates involvement of the 59 and 39 regions
in transcription (Liao and Lai, 1994; Lin et al., 1994, 1996).
Fischer et al. (1997) showed that a novel MHV sub-
genomic mRNA, which was very similar in size to MHV
mRNA 4, is synthesized in cells infected with a recom-
binant MHV, which has a non-MHV sequence in place of
gene 4. Interestingly, this recombinant MHV lacks a tran-
scription consensus sequence for this novel mRNA.
These data indicate that formation of a higher-order RNA
structure, assembled from several MHV RNA regions, is
important for transcription. Furthermore, viral proteins as
well as host-derived protein(s) are probably involved in
formation of this higher-order RNA structure (Furuya and
Lai, 1993).
If a higher-order RNA structure that is made by the 59-
and 39-regions of the genome and an intergenic se-
quence with its flanking sequences is important for coro-
navirus transcription, then probably MHV DI RNA does
not form the same structure; the MHV DI RNAs that we
used for these experiments lack most of the MHV se-
quence and contain arbitrarily located intergenic se-
quence(s). We assume that DI RNA also forms a higher-
order RNA structure, but the structure may be more
suitable for RNA replication than for transcription. This
possible difference in the higher-order RNA structures
between MHV DI RNA and infectious MHV may be re-
sponsible for the poor transcription in MHV DI RNA; the
molar ratio of mRNA 7 to mRNA 1 is about 100 (Leibowitz
et al., 1981), yet that of subgenomic DI RNA to genomic
DI RNA containing intergenic sequence and flanking
sequences at genes 6–7 is about 0.8 (Makino et al.,
1991).
The data from this study will be useful for the devel-
opment of coronavirus-based expression vectors, in
which multiple foreign genes may be expressed through
subgenomic mRNAs of genetically engineered coronavi-
ruses or coronavirus DI RNAs. There is a possibility that
only a low level of subgenomic mRNA or subgenomic DI
RNA will be synthesized in coronavirus expression vec-
tors; a low level of transcription may result from insertion
of a foreign gene downstream of the intergenic se-
quence. If this happens, as shown in this study, changing
the 0.2-kb-long upstream flanking sequence to a different
sequence, e.g., a naturally occurring upstream flanking
sequence at genes 1–2 or at 2–3, may increase tran-
scription efficiency.
The transcription step that determines the molar ratio
of subgenomic DI RNA to genomic DI RNA
Based on our characterization of the two sets of DI
RNAs shown in Fig. 6, we could not specify a coronavirus
transcription step that determines the relative ratios of
MHV mRNAs, but we can now better conceive of what
those steps may be. If subgenomic mRNAs are synthe-
sized prior to negative-strand subgenomic-sized RNA
synthesis, then they are synthesized by leader-primed
transcription, processing of positive-strand genomic
RNA, or polymerase jumping from the leader to inter-
genic sequence. In leader-primed transcription and poly-
merase jumping mechanisms, the step that determines
the relative molar ratios of mRNAs is likely to be the
leader-body fusion step. If subgenomic mRNAs are syn-
FIG. 6. Northern blot analysis of insertion mutants. Intracellular RNAs
were extracted from DI RNA-transfected, MHV-infected cells (lanes 3, 4,
9, 10) or DI RNA-transfected, mock-infected cells (lanes 1, 2, 7, 8). Lanes
5 and 6 represent RNA from MHV-infected cells. Poly(A)-containing
RNAs were analyzed by Northern blot analysis using probe 2 (see Fig.
5). Arrowhead and arrow point to subgenomic DI RNAs and genomic DI
RNAs, respectively. The minute amount of genomic DI RNA-sized signal
in lanes 7 and 8 represents the transfected DI RNA transcripts that
were not degraded in MHV-uninfected cells.
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thesized by the processing of precursor RNAs, then the
relative molar ratios of mRNAs are determined either by
the efficiency of RNA cleavage or the efficiency leader–
body fusion or both. If the subgenomic-sized negative-
strand RNAs are synthesized prior to the subgenomic
mRNAs (Sawicki and Sawicki, 1990), then the efficiency
of subgenomic-sized negative-strand RNA synthesis may
determine the relative ratios of subgenomic mRNAs; the
efficiency of subgenomic-sized negative-strand RNA syn-
thesis may be determined by the efficiency of transcrip-
tion termination at the intergenic sequence, the effi-
ciency of relocalization of negative-strand subgenomic
RNA lacking the antileader sequence to leader sequence
of genomic-sized template RNA, or the efficiency of the
processing of genomic-sized negative-strand RNA to
subgenomic-sized RNAs. If subgenomic mRNA is syn-
thesized on subgenomic-sized negative-strand RNA
lacking the antileader sequence by priming of leader
RNA, the efficiency of leader RNA priming may determine
the relative molar ratios of subgenomic mRNAs.
The effect of double intergenic sequence insertion on
subgenomic DI RNA transcription is described (Joo and
Makino, 1995; van Marle et al., 1995). We showed that
transcription from an upstream intergenic sequence is
strongly inhibited by the presence of a proximate down-
stream intergenic sequence (Joo and Makino, 1995). van
Marle et al. (1995) described that transcription from up-
stream intergenic sequence is suppressed when two
intergenic sequences are separated more than 300 nt.
As shown in the present study, the molar ratio of large
subgenomic DI RNA to genomic in FDI-2/7 M-dIG was
similar to that of genomic DI RNA to subgenomic DI RNA
in FDI-2/7 M. The same was the case with FDI-6/7 M-dIG
and FDI-6/7 M. Insertion of an additional 12-nt sequence
at a location 0.2 kb downstream from the 12-nt sequence
did not significantly suppress transcription from the up-
stream 12-nt sequence, which was inconsistent with the
data shown by van Marle et al. (1995). Our data may
indicate that transcription suppression caused by the
presence of downstream flanking sequence that is lo-
cated far away from the upstream intergenic sequence
occurs in certain DI RNAs, but is not a common property
of coronavirus transcription in general.
MATERIALS AND METHODS
Virus and cells
The plaque-cloned A59 strain of MHV (Lai et al., 1981)
was used as a helper virus. DBT cells (Hirano et al., 1974)
were used for growth of virus and RNA transfection.
DNA construction
Recombinant PCR was used to create various inser-
tions, as described previously (Higuchi, 1990). The same
PCR condition was used for all cDNA construction. Plas-
mid DNA or MHV-JHM cDNA and primers were mixed in
a PCR buffer containing 0.05 M KCl, 0.01 M Tris–HCl (pH
8.3), 0.0025 M MgCl2, 0.01% gelatin, 0.17 mM each dNTPs
and 5 U Taq polymerase (Promega). The sample was
initially incubated at 94°C for 5 min and then incubated
at 94°C for 1 min, 42°C for 1 min, and 72°C for 1 min, and
that incubation was repeated for 30 cycles. A complete
MHV DIssE cDNA clone, DE5-w3 (Makino and Lai,
1989b), was used as a parental clone for DNA construc-
tion. We obtained two 0.2-kb-long PCR products, each of
which had either the 12-nt sequence or the 18-nt se-
quence at its end, by incubating the MHV-JHM cDNA or
cloned MHV DI cDNA with two specific primers, one of
which contained either the 12-nt or 18-nt sequence. The
two purified PCR products made from each template
were mixed, and the second PCR yielded a 0.4-kb-long
product that had either the 12-nt sequence or the 18-nt
sequence in its middle. The final PCR product was in-
serted into the AflII site and SacII site of DE5-w3 to
produce the DI cDNAs used in the present study (Fig. 1).
For all of the constructs, we sequenced the inserts that
were derived from the PCR products to confirm the pres-
ence of specific sequences and the absence of extrane-
ous mutations.
RNA transcription and transfection
Plasmid DNAs were linearized by XbaI digestion and
transcribed with T7 RNA polymerase as previously de-
scribed (Makino and Lai, 1989b). DI RNA synthesized in
vitro was transfected into DBT cells that had been in-
fected with MHV 1 h prior to infection. Lipofection
(Makino et al., 1991) was used for RNA transfection.
Preparation of virus-specific intracellular RNA and
northern (RNA) blotting
Accumulation of intracellular DI RNAs were examined in
MHV-infected, DI RNA-transfected cells. Intracellular RNAs
from MHV-mock-infected, DI RNA-transfected cells and
those from MHV-infected cells were used as controls. In-
tracellular RNAs were extracted at 7 h after MHV infection
(Makino et al., 1984). In most of the experiments, poly(A)-
containing RNAs were collected by oligo(dT) column chro-
matography and characterized. Intracellular RNAs were de-
natured and electrophoresed through a 1% agarose gel
containing formaldehyde and transferred onto nylon filters
(Makino et al., 1991). Northern blot hybridization was per-
formed with a 32P-labeled random-primed probe (Jeong and
Makino, 1992). Radioactivity of individual RNA bands was
determined by phosphorimaging analysis (Molecular Dy-
namics) of the membranes.
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